Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: JOLESSA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for JOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL) from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL)

Snippet

SUPPL AP for JOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL)